全文获取类型
收费全文 | 214862篇 |
免费 | 21189篇 |
国内免费 | 9907篇 |
专业分类
耳鼻咽喉 | 1218篇 |
儿科学 | 3408篇 |
妇产科学 | 2530篇 |
基础医学 | 42113篇 |
口腔科学 | 4012篇 |
临床医学 | 16093篇 |
内科学 | 31845篇 |
皮肤病学 | 3193篇 |
神经病学 | 12683篇 |
特种医学 | 5061篇 |
外国民族医学 | 128篇 |
外科学 | 17495篇 |
综合类 | 31739篇 |
现状与发展 | 42篇 |
一般理论 | 2篇 |
预防医学 | 9738篇 |
眼科学 | 3822篇 |
药学 | 24344篇 |
62篇 | |
中国医学 | 8413篇 |
肿瘤学 | 28017篇 |
出版年
2024年 | 526篇 |
2023年 | 3044篇 |
2022年 | 5768篇 |
2021年 | 7878篇 |
2020年 | 7278篇 |
2019年 | 7059篇 |
2018年 | 6967篇 |
2017年 | 7492篇 |
2016年 | 8185篇 |
2015年 | 8959篇 |
2014年 | 13416篇 |
2013年 | 15573篇 |
2012年 | 12807篇 |
2011年 | 14662篇 |
2010年 | 11916篇 |
2009年 | 10976篇 |
2008年 | 11061篇 |
2007年 | 11123篇 |
2006年 | 9964篇 |
2005年 | 8672篇 |
2004年 | 7289篇 |
2003年 | 6142篇 |
2002年 | 4854篇 |
2001年 | 4222篇 |
2000年 | 3477篇 |
1999年 | 3032篇 |
1998年 | 2763篇 |
1997年 | 2612篇 |
1996年 | 2294篇 |
1995年 | 2161篇 |
1994年 | 1973篇 |
1993年 | 1706篇 |
1992年 | 1497篇 |
1991年 | 1404篇 |
1990年 | 1192篇 |
1989年 | 1105篇 |
1988年 | 992篇 |
1987年 | 846篇 |
1986年 | 759篇 |
1985年 | 1572篇 |
1984年 | 1715篇 |
1983年 | 1308篇 |
1982年 | 1522篇 |
1981年 | 1335篇 |
1980年 | 1065篇 |
1979年 | 967篇 |
1978年 | 680篇 |
1977年 | 540篇 |
1976年 | 565篇 |
1975年 | 386篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
Xiaoxuan Liu Ameenat L. Solebo Livia Faes Sophie Beese Tasanee Braithwaite Matthew E. Round 《Ocular immunology and inflammation》2020,28(6):898-907
ABSTRACT
Purpose
New instrument-based techniques for anterior chamber (AC) cell counting can offer automation and objectivity above clinician assessment. This review aims to identify such instruments and its correlation with clinician estimates. 相似文献112.
《Molecular immunology》2015,63(2):296-304
Regulatory B cells (Bregs) are defined by their ability to restrain inflammatory responses both in vivo and in vitro. Interleukin 10 (IL-10) production by Bregs is thought to be central to their ability to regulate inflammation, largely due to IL-10s’ ability to suppress pro-inflammatory cytokine production by effector lymphocytes and to maintain the differentiation of regulatory T cells (Tregs). However, with an increase in available published data, it has become evident that Bregs utilize a number of suppressive mechanisms in order to alter the activation of a variety of different lymphocytes. Here, we summarize the multiplicity of cellular targets of Breg-mediated suppression and describe the mechanisms employed by Bregs to suppress chronic inflammatory responses. 相似文献
113.
目的:探讨a-1,2岩藻糖基转移酶II(FUT2)在肺鳞癌中的表达情况及其对肺鳞癌细胞增殖的影响。方法:应用UALCAN数据库分析FUT2在临床肺鳞癌患者组织中的差异表达及其与肺鳞癌患者临床TNM分期、年龄及性别因素的相关性;采用瞬时转染技术,将FUT2的shRNA质粒转染进H226细胞株中构建FUT2低表达的肺鳞癌细胞模型;利用CCK-8、平板克隆及Western blot实验检测FUT2对肺鳞癌细胞的生长、单克隆细胞团形成及PCNA蛋白表达的影响。结果:FUT2在肺鳞癌尤其是肺鳞癌TNM早中期呈现高表达趋势(P<0.05),而与年龄和性别无关。低表达FUT2可以抑制肺鳞癌细胞的生长速率和单克隆细胞团的形成数,同时,可以抑制肺鳞癌细胞PCNA蛋白的表达水平,差异均有统计学意义(P<0.05)。结论:FUT2在肺鳞癌中高表达且促进肺鳞癌细胞的增殖能力,有望成为肺鳞癌的早期诊断指标。 相似文献
114.
ObjectiveProgrammed death ligand 1 (PD-L1) has been reported to be connected to prognosis in individuals with malignant pleural mesothelioma (MPM), although there is no consensus based on data from previous studies. Accordingly, this quantitative meta-analysis investigated prognostic and clinicopathological utility of PD-L1 in patients with MPM.MethodsA comprehensive search of the PubMed, Web of Science, Embase, and Cochrane Library databases for articles published up to October 4, 2019 was performed. Studies using immunohistochemical techniques to detect/quantify the expression of PD-L1 in MPM tissue were enrolled in the analysis. The combined hazard ratio (HR) and corresponding 95% confidence interval (CI) was applied to assess the association between PD-L1 expression and overall survival (OS).ResultsA total of 11 studies comprising 1606 patients was included in the present meta-analysis. For OS, pooled data revealed an HR of 1.50 (95% CI 1.32–1.70; p < 0.001), suggesting that patients with PD-L1 overexpression experience inferior OS. Subgroup analysis revealed that elevated PD-L1 remained a significant prognostic indicator for worse OS, irrespective of sample size, cut-off value, ethnicity, and Newcastle-Ottawa Scale score. Moreover, PD-L1 overexpression was associated with non-epithelioid histology (odds ratio 4.30 [95% CI 1.89–9.74]; p < 0.001).ConclusionsResults of this meta-analysis show that elevated expression of PD-L1 could be a factor predicting poorer survival in patients with MPM. 相似文献
115.
116.
117.
目的 分析m6A阅读器胰岛素样生长因子2-mRNA结合蛋白1(insulin-like growth factor 2 mRNA-binding protein 1,IGF2BP1)在肝细胞癌(hepatocellular carcinoma,HCC)中的表达水平及其对HCC患者预后的影响,并探讨IGF2BP1在HCC发生发展中的作用及其潜在机制。方法 基于5对HCC癌及相应癌旁组织mRNA-seq数据和TCGA数据库LIHC的mRNA-seq数据综合分析IGF2BP1在HCC中的表达情况,同时利用TCGA数据库中343例HCC患者的临床随访资料分析IGF2BP1表达水平对HCC患者总生存期的影响。基于TCGA数据库筛选IGF2BP1的共表达mRNA,并利用m6Avar在线网站预测mRNA的m6A位点及其RNA结合蛋白等信息,最终构建IGF2BP1的基因调控网络。结果 IGF2BP1基因在HCC中表达上调(log2FC HCC转录组数据=10.684,P<0.001;log2FC TCGA-LIHC数据集=7.032,P<0.001)。生存分析显示IGF2BP1低表达的HCC患者中位生存时间为5.84年,IGF2BP1高表达患者为4.44年,高表达患者总生存期缩短(P=0.011)。22个差异表达的mRNA与IGF2BP1存在靶向结合关系,并与其表达水平呈正相关。其中,HMGA2等15个高表达mRNA的HCC患者总生存期缩短。HMGA2、PEG10、CEP55、RHO、CDC6和KIF23基因中的潜在m6A甲基化位点位于mRNA 3'UTR端的miRNA结合区域。结论 IGF2BP1在HCC中高表达且导致患者总生存期缩短。IGF2BP1可能通过m6A甲基化及miRNA抑制作用的方式上调mRNA的表达,促进HCC发生并导致不良预后。 相似文献
118.
The peri-implantation period of pregnancy is critical for conceptus development, implantation, and signaling for establishment of pregnancy. This study evaluated the effects of bisphenol A (BPA) on proliferation, adhesion, and migration of porcine trophectoderm (pTr2) cells, expression of transporters of arginine and synthesis of amino acids. All concentrations of BPA decreased proliferation and adhesion of pTr2 cells after 96 h compared to the control group. Lower concentrations of BPA (1 × 10−9, 1 × 10-8, 10-7M) increased (P < 0.05), but higher concentrations of BPA (1 × 10-5, 1 × 10-4 M) decreased migration of pTr2 cells. BPA increased expression of SLC7A1 mRNA at lower concentrations (1 × 10−9 to 1 × 10-6M) and SL7A6, another cationic acid transporter, at higher concentrations (1 × 10-5, 1 × 10-4 M). BPA also down-regulated the expression of IGF1 and IGF1 receptor at concentrations of 1 × 10-7 to 1 × 10-4 M compared to the control group. The expression of mRNAs for aquaporins (AQP) 3 and 4 were reduced at all concentrations of BPA, but at lower concentrations of BPA, (1 × 10−9 to 1 × 10-8M) expression of AQP9 mRNA increased and the expression of AQP11 was not affected by BPA (P > 0.05). There was an inhibitory effect of BPA on the release of synthesis of asparagine, threonine, taurine, tryptophan, and ornithine into the culture medium by pTr2 cells. Collectively, BPA adversely affected the expression of transporters for cationic amino acids like arginine, as well as AQPs, IGF1, and IGF1R associated with proliferation, migration, and adhesion of pTr2 cells. Those adverse effects would likely increase pregnancy losses during the peri-implantation period of pregnancy. 相似文献
119.
AbstractThe autoimmune condition Hashimoto’s thyroiditis (HT) is a disease wherein lymphocytes mediate the autoimmune damage and destruction of the thyroid gland. There are currently no effective means of treating HT, with the primary strategies of thyroid hormone therapy, surgery, or immunomodulatory therapy being associated with serious risks and side effects. There is thus a clear and urgent need to identify novel treatments for HT. In this study, we utilize female SD rats induced HT to evaluated the ability of transplanted MSCs to regulate Th17/Treg interactions in a rat Hashimoto’s thyroiditis (HT) model system. The results showed that Rats in the HT model group exhibited increased thyroid autoantibody levels consistent with successful model development, whereas these levels were lower in rats treated with MSCs. There were also fewer thyroid lesions and less lymphoid infiltration of the thyroid in MSC-treated rats relative to HT model rats, as well as fewer Th17 cells and more Treg cells – an observation consistent with the cytokine analyses. All of these showed that MSCs can regulate Th17/Treg interactions in a rat Hashimoto’s thyroiditis (HT) model system. It suggested that transplanted MSCs could be a potential immunotherapy strategy for the treatment of Hashimoto’s thyroiditis. 相似文献
120.
《Vaccine》2020,38(32):4940-4943
To determine the duration of immunity provided by the Hepatitis A vaccination (HepA), we evaluated a cohort of participants in Alaska 20 years after being immunized as infants. At recruitment, participants received two doses of inactivated HepA vaccine on one of three schedules. We conducted hepatitis A antibody (anti-HAV) testing for participants at the 20-year time-point. Seventy-five of the original 183 participants (41%) were available for follow-up. The overall anti-HAV geometric mean concentration was 29.9 mIU/mL (95% CI 22.4 mIU/mL, 39.7 mIU/mL) and 50 participants (68%) remained seropositive (titer ≥ 20 mIU/mL). Using a fractional polynomial model, the predicted percent seropositive at 25 years was 55.3%, 49.8% at 30 years and 45.7% at 35 years, suggesting that the percent sero-positive could drop below 50% earlier than previously expected. Further research is necessary to understand if protection continues after seropositivity diminishes or if a HepA booster dose may become necessary. 相似文献